Acadia Pharmaceuticals Announces Planned Retirement of President Srdjan (Serge) Stankovic

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that its President, Srdjan (Serge) Stankovic, M.D., M.S.P.H., who is responsible for R&D, and Medical and Scientific functions, will retire at the end of the year. A search for a successor to Dr. Stankovic is ongoing. Following his retirement, Dr. Stankovic will provide consulting and advisory services for Acadia on a part-time basis. “I want to thank Serge for his seven years of dedicated service to Acad
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks